Dr. Patwari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Binney St.
Cambridge, MA 02142
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, Cardiovascular Disease, 2003 - 2006
Massachusetts Institute of TechnologyScD, electrical engineering, 1998 - 2003
Northwestern University The Feinberg School of MedicineClass of 1998
Clinical Trials
- A Study of SHP655 (rADAMTS13) in Sickle Cell Disease Start of enrollment: 2019 Oct 21
- A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura Start of enrollment: 2021 Apr 14
Publications & Presentations
PubMed
- 4 citationsRecombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.Marie Scully, Ana Antun, Spero R Cataland, Paul Coppo, Claire Dossier
The New England Journal of Medicine. 2024-05-02 - 7 citationsInteraction of ARRDC4 With GLUT1 Mediates Metabolic Stress in the Ischemic Heart.Yoshinobu Nakayama, Nobuhiro Mukai, Geri Kreitzer, Parth Patwari, Jun Yoshioka
Circulation Research. 2022-09-02 - 10 citationsTxnip C247S mutation protects the heart against acute myocardial infarctionYoshinobu Nakayama, Nobuhiro Mukai, Bing F. Wang, Kristen Yang, Parth Patwari
Journal of Molecular and Cellular Cardiology. 2021-02-27
Press Mentions
Targeted Drug-Delivery PROTEOTHERA, INC. To Present at BioTech Showcase ™ Monday, Jan. 11 at 11:30 Am PTJanuary 8th, 2016
Grant Support
- Regulation Of Redox State By Txnip In Vascular DiseaseNational Heart, Lung, And Blood Institute2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
